Privacy

Change Privacy Settings

Vontobel Gene Therapy Performance Index

Valor: 41884597 ISIN: CH0418845977 Symbol ZGENCV
Average Community Rating:
Bid (Indicative)

-

Ask (Indicative)

-

Currency

CHF

Updated at

- {{ priceHubData.timestamp | dateFormat('HH:mm', '-') }}

Change

Change %

52-week low

75,90

52-week high

107,00

Vontobel Gene Therapy Performance Index

Strategy

2017 has been seen as a breakthrough year for gene therapy, which could soon be used to cure aggressive forms of cancer, AIDS and even hereditary diseases. Gene therapy is a key technology in the healthcare sector that is regarded as having great potential. Could it be a megatrend that investors will profit from in the near future? Provided the market players involved achieve commercial success, including it in a portfolio at an early stage could add an innovative touch. Besides attractive return prospects, gene therapy offers diversification benefits for a classic investment portfolio that consists mainly of core investments or only contains “conventional” pharmaceuticals.

Performance & Risk

Three Months YTD 2019 2017 2015 Since Inception
Vontobel Gene Therapy Performance Index 20,63% 0,68% 48,35% - - 5,26%
Three Months
20,63%
YTD
0,68%
2019
48,35%
2017
-
2015
-
Since Inception
5,26%

The figures given refer to past performance. Past performance is not a reliable indicator of future performance and should not be the sole decision factor in the selection of a financial instrument. The performance of the financial instrument is displayed on the basis of valuation prices in the investment currency, with reinvested net income. Due to currency fluctuations, your return may be higher or lower if you invest in a currency other than the one in which the past performance has been calculated. All price information relates to the product unless otherwise indicated.

Risk Indicator

The risk indicator is a guide to the level of risk of this product compared to other products.

Index Composition

Breakdown

Master Data

Master Data

Product Type Tracker Certificate
Issue Date 13/07/2018
Issue Price 101,50
Ratio 0,996512
Index Vontobel Gene Therapy Performance Index
Currency CHF
Markets(s) SIX SWISS EXCHANGE – STRUCTURED PRODUCTS
Currency Hedged No
Index adjustments According to the Index Guide

Parties

Issuer Bank Vontobel AG, Zurich

Costs

Management Fee 1,20
Performance Fee -

Documents

Factsheet

Factsheet

Deutsch
English
Español
Français
Italiano
Svenska
Termsheet

Termsheet

Deutsch
English
Français
Italiano
KID

KID

Čeština
Dansk
Deutsch
English
Español
Français
Italiano
Magyar
Nederlands
Norsk
Suomi
Svenska